EW:NYSE
Edwards Lifesciences Corp
US$107,15
arrow_upward
+1,19%(+1,26) 1D
US$106,50
arrow_downward
-0,61% (-0,65)bedtimeAfter hours
Closed: 13 ພ.ຈ., 16 ໂມງ 0 ນາທີ 04 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
US$106,10
High
US$107,69
Low
US$106,01
Mkt. cap
61,61 ຕື້
Avg. vol.
4,51 ລ້ານ
Volume
3,82 ລ້ານ
P/E ratio
60,75
52-wk high
US$107,69
52-wk low
US$74,66
EPS
US$1,76
Beta
0,85
Shares outstanding
575,00 ລ້ານ
No. of employees
16 ພັນ
Open
US$106,10
High
US$107,69
Low
US$106,01
Mkt. cap
61,61 ຕື້
Avg. vol.
4,51 ລ້ານ
Volume
3,82 ລ້ານ
P/E ratio
60,75
52-wk high
US$107,69
52-wk low
US$74,66
EPS
US$1,76
Beta
0,85
Shares outstanding
575,00 ລ້ານ
No. of employees
16 ພັນ
News stories
From web sources and news partners
Traders Union
·
12 ຊົ່ວໂມງກ່ອນ
MarketWise: Edwards Lifesciences revenue climbs 10.5 percent, earnings surge 19 percent
Trefis
·
1 ມື້ກ່ອນ
Is There Any Reason To Invest In Edwards Lifesciences Stock?
Zacks
·
1 ມື້ກ່ອນ
Top Stock Reports for Visa, ExxonMobil & Pfizer
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 ພັນ
Founded1958
Headquartersເອີວິນ, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth Care
IndustryMedical device
Websiteedwards.com